Jazz Pharmaceuticals plc (JAZZ) stock
JAZZNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 7/30122% above fair value
$240.71+0.94 (+0.39%)
Close on Nov 17, 2026Market cap $15.63BP/E 78.4Yield –
Jazz Pharmaceuticals market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Jazz Pharmaceuticals's market cap was $16.01B on Nov 11, 2026, against $10.83B a year earlier. Over the last 5 years it ranged from $6.77B to $16.17B, with a median of $8.58B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $16.01B | +53.6% |
| 2025 | Dec 31, 2025 | $10.43B | +27.8% |
| 2024 | Dec 31, 2024 | $8.16B | -4.8% |
| 2023 | Dec 29, 2023 | $8.57B | -14.2% |
| 2022 | Dec 30, 2022 | $9.98B | +32.6% |
| 2021 | Dec 31, 2021 | $7.53B | -19.0% |
| 2020 | Dec 31, 2020 | $9.30B | +6.8% |
| 2019 | Dec 31, 2019 | $8.71B | +14.4% |
| 2018 | Dec 31, 2018 | $7.61B | -7.7% |
| 2017 | Dec 29, 2017 | $8.25B | +21.4% |
| 2016 | Dec 30, 2016 | $6.80B | -26.0% |
| 2015 | Dec 31, 2015 | $9.18B | -8.5% |
| 2014 | Dec 31, 2014 | $10.04B | +29.1% |
| 2013 | Dec 31, 2013 | $7.78B | +157.4% |
| 2012 | Dec 31, 2012 | $3.02B | +71.5% |
| 2011 | Dec 30, 2011 | $1.76B | +198.3% |
| 2010 | Dec 31, 2010 | $590.75M | – |
See a number that looks wrong?